1,2,4-triazine has been researched along with pyrroles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albom, MS; Angeles, TS; Breslin, HJ; Dorsey, BD; Gingrich, DE; Huang, Z; Lisko, JG; Mason, JL; Milkiewicz, KL; Thieu, TV; Underiner, TL; Weinberg, LR; Wells, GJ; Wells-Knecht, KJ | 1 |
| Bi, X; Huang, D; Huang, W; Qian, H; Qiang, H; Shi, W | 1 |
2 other study(ies) available for 1,2,4-triazine and pyrroles
| Article | Year |
|---|---|
2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation.
Topics: Amino Acid Substitution; Glutathione; Humans; Janus Kinase 2; Myeloproliferative Disorders; Protein Kinase Inhibitors; Pyrroles; Structure-Activity Relationship; Triazines | 2011 |
Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrroles; Triazines; Vascular Endothelial Growth Factor Receptor-2 | 2018 |